secwatch.observer — SEC 8-K summary
======================================

Issuer:     BOSTON SCIENTIFIC CORP (BSX)
CIK:        0000885725
Form:       8-K
Filed at:   2024-11-22T23:59:59+00:00
Accession:  0000885725-24-000081
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Boston Scientific approves 2025 bonus plan and two performance share programs
-----------------------------------------------------------------------------

- 2025 Annual Bonus Plan: target bonus pool with payout 0%-150% based on global sales, adjusted EPS, operating income and ESG goals.
- 2025 rTSR PSP: awards 0%-200% of target based on TSR vs S&P 500 Healthcare Index over 2025-2027.
- 2025 Organic Net Sales PSP: awards 0%-200% of target based on organic net sales growth vs financial plan over 2025-2027.
- Awards subject to Dodd-Frank clawback policy and discretionary recoupment for executive misconduct or harm.
- Retirement eligibility requires age 55, 5 years service, sum ≥65; retirement before Jan 1, 2026 forfeits performance shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/885725/000088572524000081/0000885725-24-000081-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/885725/000088572524000081/bsx-20241119.htm
  HTML page:      https://secwatch.observer/filing/0000885725-24-000081

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer